Guizhou Yibai Pharmaceutical Co Ltd (600594)

Shanghai
Currency in CNY
4.15
+0.04(+0.97%)
Closed·
600594 Scorecard
Full Analysis
High shareholder yield
600594 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.084.15
52 wk Range
2.894.53
Key Statistics
Edit
Bid/Ask
4.14 / 4.15
Prev. Close
4.11
Open
4.1
Day's Range
4.08-4.15
52 wk Range
2.89-4.53
Volume
14.19M
Average Volume (3m)
17.16M
1-Year Change
33.66%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600594 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Guizhou Yibai Pharmaceutical Co Ltd Company Profile

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, analgesic, cancer, orthopedics, digestion, andrology, and urology. The company also engages in investment in the cultivation and breeding projects of medicinal materials; and agricultural products sale, as well as provides market information consulting services for medicinal materials; and research and development, and information consulting services for health food. Guizhou Yibai Pharmaceutical Co., Ltd. was founded in 1995 and is headquartered in Guiyang, China.

Employees
5261
Market
China

Compare 600594 to Peers and Sector

Metrics to compare
600594
Peers
Sector
Relationship
P/E Ratio
−12.4x−21.5x−0.5x
PEG Ratio
0.000.060.00
Price/Book
1.3x3.1x2.6x
Price / LTM Sales
1.5x7.3x3.2x
Upside (Analyst Target)
-−3.1%45.9%
Fair Value Upside
Unlock−17.0%7.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.33%
Dividend Yield
-
Industry Median 1.57%
Annualised payout
-
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
501.48M / --
EPS Revisions
Last 90 days

600594 Income Statement

FAQ

What Stock Exchange Does Guizhou Yibai Pharm Trade On?

Guizhou Yibai Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Guizhou Yibai Pharm?

The stock symbol for Guizhou Yibai Pharm is "600594."

What Is the Guizhou Yibai Pharm Market Cap?

As of today, Guizhou Yibai Pharm market cap is 3.26B.

What Is Guizhou Yibai Pharm's Earnings Per Share (TTM)?

The Guizhou Yibai Pharm EPS (TTM) is -0.33.

From a Technical Analysis Perspective, Is 600594 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Guizhou Yibai Pharm Stock Split?

Guizhou Yibai Pharm has split 7 times.

How Many Employees Does Guizhou Yibai Pharm Have?

Guizhou Yibai Pharm has 5261 employees.

What is the current trading status of Guizhou Yibai Pharm (600594)?

As of 14 Jul 2025, Guizhou Yibai Pharm (600594) is trading at a price of 4.15, with a previous close of 4.11. The stock has fluctuated within a day range of 4.08 to 4.15, while its 52-week range spans from 2.89 to 4.53.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.